Company profile
LimmaTech Biologics company profile
LimmaTech Biologics is a clinical-stage biotech company that develops vaccines to prevent life-threatening diseases. The company uses proprietary self-adjuvanting and multi-antigen vaccine platforms to address microbial infections that are becoming resistant to treatments. Its research and development efforts aim to create vaccines tailored to specific pathogens. LimmaTech Biologics works on expanding its pipeline to provide solutions for infectious diseases with limited treatment options.
Business identity
- Website
- https://lmtbio.com/
- Contact email
- [email protected]
- Phone number
- +41 44 733 8585
- Operating status
- Active
- Company type
- For Profit
- Employee range
- 101-250 employees
- Revenue range
- $0-$1M
- Founded
- 2015-01-01, Year
Headquarters
- Headquarters
- Schlieren, Zurich, Switzerland
- Postal code
- 8952
- Country code
- CH
- Continent
- Europe